factual
Rosiglitazone Caused ~70,000 Heart Attacks
Rosiglitazone, a Type 2 diabetes drug, was on the market for years (and as of last check still available in the US) when a 2007 meta-analysis suggested it had caused something like 70,000 heart attacks; of roughly 45 trials testing it, only about 15 had been published.
factualpending
Speaker
Jacob StegengaEvidence Quote
“in 2007, meta-analysis was done which suggested that in the handful of years that the drug had been on the market, it had caused something like 70,000 heart attacks.”
Created: 6/13/2026, 12:09:58 AM
Your notes
Loading notes...